Stage 4 pancreatic adenocarcinoma harbouring an FGFR2-TACC2 fusion mutation with complete response to erdafitinib a pan-fibroblastic growth factor receptor inhibitor.
BMJ case reports | 2021-09-12 | PMID 34511423
Poon Donald, Tan Min Han, Khor Damian
